Resources
Filters
Evidation Insights from 165,000 People Show Continued Growth Potential Amid Uneven Adoption in the GLP-1 Market
Evidation Insights from 165,000 People Show Continued Growth Potential Amid Uneven Adoption in the GLP-1 Market
Evidation Insights from 165,000 People Show Continued Growth Potential Amid Uneven Adoption in the GLP-1 Market
Evidation Insights from 165,000 People Show Continued Growth Potential Amid Uneven Adoption in the GLP-1 Market
Among 119,000 surveyed individuals actively trying to lose weight, 24% had ever used prescription medication for weight management and 15% had ever used a GLP-1, suggesting significant room for continued market growth as adoption varies by age, gender, and income.

ISPOR 2026 Recap: Understanding Health Between Visits
ISPOR 2026 Recap: Understanding Health Between Visits
ISPOR 2026 Recap: Understanding Health Between Visits
ISPOR 2026 Recap: Understanding Health Between Visits
Evidation’s research at ISPOR 2026 highlighted the growing need for direct, longitudinal patient data to better understand real-world outcomes

Creating a Complete View of Dermatology Care to Strengthen Brand and Portfolio Decisions to Drive Competitive Advantage
Creating a Complete View of Dermatology Care to Strengthen Brand and Portfolio Decisions to Drive Competitive Advantage
Creating a Complete View of Dermatology Care to Strengthen Brand and Portfolio Decisions to Drive Competitive Advantage

Creating a Complete View of Dermatology Care to Strengthen Brand and Portfolio Decisions to Drive Competitive Advantage
Explore how longitudinal, multimodal real-world data collected through direct connections to individuals can sharpen brand positioning, clarify unmet need, and strengthen lifecycle and access strategy in competitive dermatology markets.

Evidation Launches Interactive Dermatology Cohort; Shares Preliminary Real-World Insights
Evidation Launches Interactive Dermatology Cohort; Shares Preliminary Real-World Insights
Evidation Launches Interactive Dermatology Cohort; Shares Preliminary Real-World Insights
Evidation Launches Interactive Dermatology Cohort; Shares Preliminary Real-World Insights
New cohort is designed to address gaps in understanding treatment journeys across the full continuum of care. Insights show that consumer health products play a critical part in how individuals understand and manage their skin conditions.

Enabling Next-Generation AI in Autoimmune R&D
Enabling Next-Generation AI in Autoimmune R&D
Enabling Next-Generation AI in Autoimmune R&D

Enabling Next-Generation AI in Autoimmune R&D
Explore how longitudinal, temporally relevant, multimodal data collected through direct connections with individuals can help unlock new opportunities across early R&D for immune-mediated diseases.

Building with Patients: A Conversation with Rachel Sha, CEO of Vaxess Technologies
Building with Patients: A Conversation with Rachel Sha, CEO of Vaxess Technologies
Building with Patients: A Conversation with Rachel Sha, CEO of Vaxess Technologies
Building with Patients: A Conversation with Rachel Sha, CEO of Vaxess Technologies
Vaxess Technologies CEO Rachel Sha shares how patient voices are driving new delivery solutions for anti-obesity medications, with the potential to dramatically expand access and improve adherence.

Evidation partners with 1upHealth to integrate diverse sources of permissioned real-world health data for research
Evidation partners with 1upHealth to integrate diverse sources of permissioned real-world health data for research
Evidation partners with 1upHealth to integrate diverse sources of permissioned real-world health data for research

Evidation partners with 1upHealth to integrate diverse sources of permissioned real-world health data for research
Evidation and 1upHealth announce a long-term partnership to advance patient-centered, real-world health research.

Better data, better outcomes: Weight management
Better data, better outcomes: Weight management
Better data, better outcomes: Weight management

Better data, better outcomes: Weight management
Survey + wearable data from Evidation members about their weight management experiences have highlighted real-world priorities, challenges, and opportunities in this space. Watch our Lunch & Learn to learn more.

REVEAL, a prospective, observational study
REVEAL, a prospective, observational study
Elizabeth A. Griffiths, Jae S. Min, Wei-Nchih Lee, Jeffrey C. Yu, Yogesh Patel, Karl-Johan Myren, & David Dingli
REVEAL, a prospective, observational study
Elizabeth A. Griffiths, Jae S. Min, Wei-Nchih Lee, Jeffrey C. Yu, Yogesh Patel, Karl-Johan Myren, & David Dingli

REVEAL, a prospective, observational study
Evidation and partners aimed to examine the impact of paroxysmal nocturnal hemoglobinuria (PNH) and its treatment on patients’ daily lives by combining patient-reported outcomes with wearable technology.
Elizabeth A. Griffiths, Jae S. Min, Wei-Nchih Lee, Jeffrey C. Yu, Yogesh Patel, Karl-Johan Myren, & David Dingli

Equitable research drives equitable health care: The power of patient-reported outcomes (PROs)
Equitable research drives equitable health care: The power of patient-reported outcomes (PROs)
Equitable research drives equitable health care: The power of patient-reported outcomes (PROs)

Equitable research drives equitable health care: The power of patient-reported outcomes (PROs)
Learn how integrating participant-reported outcome (PRO) data with social determinants of health (SDOH) can identify and address disparities in access to care, treatment outcomes, and satisfaction with health care.

No results found. Try broadening your search for more results!